EirGen Pharma invests €12m in Waterford

EirGen Pharma expands manufacturing capabilities to support global customer base.

EirGen Pharma has acquired a new building in the IDA Industrial Estate in Waterford which will facilitate an expansion of its Oral Solid Dose manufacturing and packaging capabilities.

The new facility will provide an additional 3,500 square metres of state-of-the-art manufacturing and packaging capabilities for its global customer base.

“The acquisition of this building and adjoining 1.2-hectare site strategically positions the business for sustained growth over the next 10 years”

This expansion has been planned since summer 2021, when EirGen Pharma agreed to sell its Sterile Fill Finish capability to Horizon Therapeutics plc. Within the sale was the Sterile Fill Finish technology and the EirGen Pharma Building at Butlerstown, Waterford.

At the time EirGen Pharma’s parent company OPKO Health committed to investing in the growth and development of its core EirGen business in Waterford, consisting of Oral Solid Dose technology for R&D and Commercial supply to global markets from Waterford City.

Building for tomorrow

“The acquisition of this building and adjoining 1.2-hectare site strategically positions the business for sustained growth over the next 10 years,” said EirGen CEO Damien Burke.

“It also represents a significant vote of confidence by the OPKO board in the capability of our employees, our leadership team in EirGen and Waterford as a locality to expand our business. This expansion will see up to €12m invested locally throughout the construction phase in 2022/2023.

EirGen Pharma develops and supplies high potency specialty care medicines to patients in more than fifty countries worldwide. It was established in 2005 and has been part of OPKO Health since 2015.

Construction and fit out will commence in Q3 2022 with commercial operations starting in Q1 2024.

EirGen has and will continue to be supported by the Irish Government through IDA Ireland.

“This site and building acquisition by EirGen marks a significant milestone in the company’s evolution and growth in Waterford,” said IDA Ireland CEO Martin Shanahan.

“It has, with this development, strongly endorsed Waterford and the South East Region as an excellent location for its continued development and future growth.”

John Kennedy
Award-winning ThinkBusiness.ie editor John Kennedy is one of Ireland's most experienced business and technology journalists.

Recommended